Cathy S.J. Fann
Academia Sinica
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Cathy S.J. Fann.
PLOS Genetics | 2010
Fuu Jen Tsai; Chi Fan Yang; Ching Chu Chen; Lee-Ming Chuang; Chieh Hsiang Lu; Chwen Tzuei Chang; Tzu Yuan Wang; Rong Hsing Chen; Chiung Fang Shiu; Yi Min Liu; Chih Chun Chang; Pei Chen; Chien-Hsiun Chen; Cathy S.J. Fann; Yuan-Tsong Chen; Jer-Yuarn Wu
To investigate the underlying mechanisms of T2D pathogenesis, we looked for diabetes susceptibility genes that increase the risk of type 2 diabetes (T2D) in a Han Chinese population. A two-stage genome-wide association (GWA) study was conducted, in which 995 patients and 894 controls were genotyped using the Illumina HumanHap550-Duo BeadChip for the first genome scan stage. This was further replicated in 1,803 patients and 1,473 controls in stage 2. We found two loci not previously associated with diabetes susceptibility in and around the genes protein tyrosine phosphatase receptor type D (PTPRD) (P = 8.54×10−10; odds ratio [OR] = 1.57; 95% confidence interval [CI] = 1.36–1.82), and serine racemase (SRR) (P = 3.06×10−9; OR = 1.28; 95% CI = 1.18–1.39). We also confirmed that variants in KCNQ1 were associated with T2D risk, with the strongest signal at rs2237895 (P = 9.65×10−10; OR = 1.29, 95% CI = 1.19–1.40). By identifying two novel genetic susceptibility loci in a Han Chinese population and confirming the involvement of KCNQ1, which was previously reported to be associated with T2D in Japanese and European descent populations, our results may lead to a better understanding of differences in the molecular pathogenesis of T2D among various populations.
Vaccine | 2001
Cheng-Nan Wu; Ya-Ching Lin; Cathy S.J. Fann; Nan-Shih Liao; Shin-Ru Shih; Mei-Shang Ho
Enterovirus 71 (EV71), the newest member of Enteroviridae, is notable for its etiological role in epidemics of severe neurological diseases in children. Developing effective vaccines is considered a top choice among all control measures. We compared the inactivated virus vaccine (10 microg protein/mouse) with subunit vaccines--VP1 DNA vaccine (100 microg/mouse) or recombinant VP1 protein (10 microg/mouse)--in its ability to elicit maternal antibody and to provide protection against lethal infection of EV71 in suckling mice. Prior to gestation, all three groups of vaccinated dams possessed similar levels of neutralizing antibody. With a challenge dose of 2300 LD(50) virus/mouse, suckling mice born to dams immunized with inactivated virus showed 80% survival. The subunit vaccines provided protection only at a lower challenge dosage of 230 LD(50) per mouse, with 40% survival for DNA vaccine and 80% survival for VP1 protein. The cytokine profile produced by splenocytes showed a high level of IL-4 in the inactivated virus group, high levels of IFN-gamma and IL-12 in the DNA vaccine group, and high levels of IL-10 and IFN-gamma in the VP1 protein group. Overall, the inactivated virus elicited a much greater magnitude of immune response than the subunit vaccines, including total IgG, all four IgG subtypes, and T-helper-cell responses; these antibodies were shown to be protective against lethal infection when passively transferred to susceptible newborn mice. Our data indicated that inactivated virus is the choice of vaccine preparation capable of fulfilling the demand for effective control, and that VP1 subunit vaccines remain promising vaccine strategies that require further refinement.
Human Heredity | 2006
Wen-Harn Pan; Cathy S.J. Fann; Jer-Yuarn Wu; Yung-Tai Hung; Mei-Shang Ho; Terence Hua Tai; Ying-Ju Chen; Chung-Ju Liao; Meng-Li Yang; Andrew Cheng; Yuan-Tsong Chen
a Institute of Biomedical Sciences, Academia Sinica, b Department of Political Sciences, National Taiwan University, c Research Center for Humanities and Social Sciencies, Academia Sinica, d Center for Survey Research, Research Center for Humanities and Social Sciencies, Academia Sinica, and e Department of Philosophy, National Chengchi University, Taipei , Taiwan, ROC goal is to develop Taiwan’s competitive edge in medical research particularly for prognosis, diagnosis, and treatment of Taiwanese important genetic diseases. The Han Chinese cell and Genome Bank project was jointly supported by NRPGM and Academia Sinica. Comprehensive cores have been established in NRPGM to complement relevant studies. The National Clinical Core and National High-throughput Genotyping Core, funded by NSC and directed by the Institute of Biomedical Sciences, Academia Sinica, Taiwan, played major roles in carrying out fi eld work and in the genotyping of the genetic material. A policy and mechanisms for the release of DNA information have been established for genetic research communities in Taiwan and abroad. In order to obtain a representative sample of genetic material for the bank; a stratifi ed, 3-staged, probability clustering sampling scheme (see appendix, table 1 , and fi g. 1 ) was adopted. Sampling was designed to have around 278 male and 278 female subjects respectively in each of the 6 age groups (20–, 30–, 40–, 50–, 60–, 70–) so that there would be suffi cient numbers of sex/age matched controls for a range of diseases. Of the people living in the registered households that were contacted, a total of 73.4% took part in the study. Plasma, DNA, and lymphocytes were collected and banked, and measurements including basic blood chemistry, blood pressure, peak fl ow, and anthropometric parameters were taken (see table 2 ). A questionnaire ( table 2 ) on ethnicity, disease history and medication, life styles, and cognitive function of the elderly was administered by trained nurses in a door-to-door survey, following a standardized protocol. Complete questionnaire and bio-specimen data were available for 3,380 people. This information can be used to defi ne phenotypes for association study and to select controls. The EBV-transformed lymphoblastoid cell lines had been established by the Bioresource Collection and Research Center, Hsinchu, Taiwan. From October 1, 2002 to January 14, 2004, the Institute of Biomedical Sciences, Academia Sinica, Taiwan, conducted fi eld work involving interviewing and recruiting 3,380 Han Chinese in order to establish a Han Chinese Cell and Genome Bank in Taiwan. The aims of this undertaking were several fold: (1) to collect representative genetic material for population genetic research, particularly for use as controls in disease association studies in Chinese people, (2) to document the genetic diversity of Han Chinese in Taiwan at the beginning of the 21st century, and (3) to create a bank of material that will prevent the repetitive collection of genetic material from the general public by the academic and medical community. The National Science Council (NSC) in Taiwan has launched the ‘National Research Program for Genomic Medicine (NRPGM)’ in 2002 as the fi rst phase of Taiwan’s Biotechnology Initiative in response to the deciphering of the human genome in 2000. The
International Journal of Cancer | 2005
Yen-Li Lo; Jyh-Cherng Yu; Shou-Tung Chen; Hsin-Chou Yang; Cathy S.J. Fann; Yi-Chien Mau; Chen-Yang Shen
Aneuploidy, an abnormal number of chromosomes, is relatively common and occurs early in breast cancer development. This observation supports a breast tumorigenic contribution of mechanisms responsible for maintaining chromosome number stability in which centrosomes play an essential role. We therefore speculated that the Aurora‐A/STK15/BTAK gene, implicated in the regulation of centrosome duplication, may be associated with breast tumorigenesis. To test this hypothesis, we conducted a case‐control study of 709 primary breast cancer patients and 1,972 healthy controls, examining single‐nucleotide polymorphisms (SNPs), including a suggested functional Phe31Ile SNP, in Aurora‐A. We were also interested in knowing whether any association between Aurora‐A and breast cancer was modified by reproductive risk factors reflecting susceptibility to estrogen exposure. Our hypothesis is that, since estrogen is known to promote breast cancer development via its mitogenic effect leading to malignant proliferation on breast epithelium and since Aurora‐A is involved in regulating mitosis, the discovery of a joint effect between the Aurora‐A genotype and reproductive risk factors on cancer risk might yield valuable clues to the association of breast tumorigenesis with estrogen. Support for this hypothesis came from the following observations. (i) Two SNPs in Aurora‐A were significantly associated with breast cancer risk (p < 0.05). (ii) Haplotype analyses, based on different combinations of multiple SNPs in Aurora‐A, revealed a strong association with breast cancer risk; interestingly, the genotypic distribution of the suggested functional Phe31Ile SNP was not significantly different between breast cancer patients and controls, but the specific haplotype containing the putative at‐risk Ile allele was more common in patients. (iii) This association between risk and putative high‐risk genotypes was stronger and more significant in women thought to be more susceptible to estrogen, i.e., those with a longer interval between menarche and first full‐term pregnancy. (iv) The protective effect conferred by a history of full‐term pregnancy was significant only in women with a putative low‐risk genotype of Aurora‐A. Our study provides new findings supporting the mutator role of Aurora‐A in breast cancer development, suggesting that breast cancer could be driven by genomic instability associated with variant Aurora‐A, the tumorigenic contribution of which could be enhanced as a result of increased mitosis due to estrogen exposure.
Biological Psychiatry | 2006
Yu-Li Liu; Cathy S.J. Fann; Chih-Min Liu; Wei J. Chen; Jer-Yuarn Wu; Shuen-Iu Hung; Chun-Houh Chen; Yuh-Shan Jou; Shih-Kai Liu; Tzung-Jeng Hwang; Ming H. Hsieh; Wen-Chen Ou-Yang; Hung-Yu Chan; Jiann-Jyh Chen; Wei-Chih Yang; Chin-Yu Lin; Sandy F.-C. Lee; Hai-Gwo Hwu
BACKGROUND The marker D1S251 of chromosome 1q42.1 showed significant association with schizophrenia in a Taiwanese sample. We used single nucleotide polymorphism (SNP) fine mapping to search for the vulnerability genes of schizophrenia. METHODS We selected 120 SNPs covering 1 Mb around D1S251 from the public database. These selected SNPs were initially validated if allele frequency was >10%. Forty-seven validated SNPs were genotyped in 102 families with at least 2 siblings affected with schizophrenia. RESULTS Two SNP blocks showed significant association with schizophrenia. Block 1 (five-SNP), located between intron 2 and intron 13 of the glyceronephosphate O-acyltransferase (GNPAT) gene, showed the most significant associations using single-locus TDT (z = -2.07, p = .038, df = 1) and haplotype association analyses (z = -1.99, p = .046, df = 1). Block 2 (two-SNP), located between intron 4 and intron 5 of the disrupted-in-schizophrenia 1 (DISC1) gene, also showed the most significant results in both the single-locus (z = -3.22, p = .0013, df = 1) and haplotype association analyses (z = 3.35, p = .0008, df = 1). The association of the DISC1 gene with schizophrenia was mainly in the patient group with sustained attention deficits as assessed by the Continuous Performance Test. CONCLUSIONS Chromosome 1q42.1 harbors GNPAT and DISC1 as candidate genes for schizophrenia, and DISC1 is associated with sustained attention deficits.
PLOS ONE | 2009
Hsin-Chou Yang; Yu-Jen Liang; Yi-Lin Wu; Chia-Min Chung; Kuang-Mao Chiang; Hung-Yun Ho; Chih-Tai Ting; Tsung-Hsien Lin; Sheng-Hsiung Sheu; Wei-Chuan Tsai; Jyh-Hong Chen; Hsin-Bang Leu; Wei-Hsian Yin; Ting-Yu Chiu; Chin-Iuan Chen; Cathy S.J. Fann; Jer-Yuarn Wu; Teng-Nan Lin; Shing-Jong Lin; Yuan-Tsong Chen; Jaw-Wen Chen; Wen-Harn Pan
Young-onset hypertension has a stronger genetic component than late-onset counterpart; thus, the identification of genes related to its susceptibility is a critical issue for the prevention and management of this disease. We carried out a two-stage association scan to map young-onset hypertension susceptibility genes. The first-stage analysis, a genome-wide association study, analyzed 175 matched case-control pairs; the second-stage analysis, a confirmatory association study, verified the results at the first stage based on a total of 1,008 patients and 1,008 controls. Single-locus association tests, multilocus association tests and pair-wise gene-gene interaction tests were performed to identify young-onset hypertension susceptibility genes. After considering stringent adjustments of multiple testing, gene annotation and single-nucleotide polymorphism (SNP) quality, four SNPs from two SNP triplets with strong association signals (−log10(p)>7) and 13 SNPs from 8 interactive SNP pairs with strong interactive signals (−log10(p)>8) were carefully re-examined. The confirmatory study verified the association for a SNP quartet 219 kb and 495 kb downstream of LOC344371 (a hypothetical gene) and RASGRP3 on chromosome 2p22.3, respectively. The latter has been implicated in the abnormal vascular responsiveness to endothelin-1 and angiotensin II in diabetic-hypertensive rats. Intrinsic synergy involving IMPG1 on chromosome 6q14.2-q15 was also verified. IMPG1 encodes interphotoreceptor matrix proteoglycan 1 which has cation binding capacity. The genes are novel hypertension targets identified in this first genome-wide hypertension association study of the Han Chinese population.
Alcoholism: Clinical and Experimental Research | 2004
El Wui Loh; Cathy S.J. Fann; Yuh Terng Chang; Ching Jui Chang; Andrew Cheng
BACKGROUND Nonselective opioid antagonists reduce alcohol consumption under various experimental situations, and several association studies have examined possible roles of opioid receptor mu (OPRM), delta (OPRD), and kappa (OPRK) genes in the development of alcohol dependence. METHODS We examined 20 single nucleotide polymorphisms (SNPs) across the OPRM, OPRD, and OPRK genes in 158 alcohol-dependent subjects and 149 controls. Differences in allele frequency and genotype distribution between case subjects and controls, as well as the deviation from Hardy-Weinberg equilibrium, were examined using Fishers exact tests. RESULTS No significant difference in either allele or genotype frequency was found between case subjects and controls for each of the SNPs. CONCLUSIONS Our findings do not support a possible role of the opioid receptor genes for the proclivity to alcohol dependence in the Taiwanese Han.
Schizophrenia Research | 2006
Yu-Li Liu; Cathy S.J. Fann; Chih-Min Liu; Chien Ching Chang; Jer-Yuarn Wu; Shuen-Iu Hung; Shih-Kai Liu; Ming H. Hsieh; Tzung-Jeng Hwang; Hung-Yu Chan; Jiahn-Jyh Chen; Stephen V. Faraone; Ming T. Tsuang; Wei J. Chen; Hai-Gwo Hwu
The genes of D-amino acid oxidase (DAAO) activator (DAOA or G72; 13q34) and DAAO (12q24) have been suggested as candidate genes and involved in the N-methyl-D-aspartate receptor regulation pathway for schizophrenia. In order to evaluate the potential association of these two genes with schizophrenia in a Taiwanese sample, three single nucleotide polymorphisms (SNPs) for DAAO (rs2111902, rs3918346, rs3741775) and eleven SNPs for G72 (rs3916965, rs3916966, rs3916967, rs2391191, rs3916968, rs947267, rs778294, rs3916970, rs3916971, rs778293, rs3918342) were genotyped by the MALDI-TOF mass spectrometry method in 218 families (864 individuals) containing at least two siblings affected with schizophrenia. In SNP-based single locus association analyses, neither G72 nor DAAO showed significant association with schizophrenia. Additionally, a three-SNP haplotype in DAAO, and a four-SNP as well as a two-SNP haplotype in G72, showed no significant associations with schizophrenia. These results suggest that the DAAO and G72 genes are not susceptibility genes for schizophrenia in a Taiwanese sample.
Genes, Chromosomes and Cancer | 2002
Chew-Wun Wu; Gen-Der Chen; Cathy S.J. Fann; Anna F.-Y. Lee; Chin-Wen Chi; Jacqueline Ming Liu; Ulli Weier; Jeou-Yuan Chen
Gastric carcinoma (GC) is one of the most common malignancies worldwide and has a very poor prognosis. Genetic imbalances in 62 primary gastric adenocarcinomas of various histopathologic types and pathologic stages and six gastric cancer–derived cell lines were analyzed by comparative genomic hybridization, and the relationship of genomic abnormalities to clinical features in primary GC was evaluated at a genome‐wide level. Eighty‐four percent of the tumors and all six cell lines showed DNA copy number changes. The recurrent chromosomal abnormalities including gains at 15 regions and losses at 8 regions were identified. Statistical analyses revealed that gains at 17q24‐qter (53%), 20q13‐qter (48%), 1p32–p36 (42%), 22q12‐qter (27%), 17p13‐pter (24%), 16p13‐pter (21%), 6p21‐pter (19%), 20p12‐pter (19%), 7p21‐pter (18%), 3q28‐qter (8%), and 13q13–q14 (8%), and losses at 18q12‐qter (11%), 3p12 (8%), 3p25‐pter (8%), 5q14–q23 (8%), and 9p21‐p23 (5%), are associated with unique patient or tumor‐related features. GCs of differing histopathologic features were shown to be associated with distinct patterns of genetic alterations, supporting the notion that they evolve through distinct genetic pathways. Metastatic tumors were also associated with specific genetic changes. These regions may harbor candidate genes involved in the pathogenesis of this malignancy.
Biological Psychiatry | 2008
Yu-Li Liu; Cathy S.J. Fann; Chih-Min Liu; Wei J. Chen; Jer-Yuarn Wu; Shuen-Iu Hung; Chun-Houh Chen; Yuh-Shan Jou; Shi-Kai Liu; Tzung-Jeng Hwang; Ming H. Hsieh; Chien Ching Chang; Wei-Chih Yang; Jin-Jia Lin; Frank Huang-Chih Chou; Stephen V. Faraone; Ming T. Tsuang; Hai-Gwo Hwu
BACKGROUND In a previous linkage study of schizophrenia that included Taiwanese samples, the marker D22S278 (22q12.3) was significantly linked to schizophrenia (p = .001). METHODS We conducted fine mapping of the implicated genomic region, with 47 validated single nucleotide polymorphism (SNP) markers around 1 Mb of D22S278, in a Taiwanese sample of 218 pedigrees with at least 2 siblings affected with schizophrenia. We examined the association of these SNPs and their haplotypes with schizophrenia and with subgroups defined by the presence and absence of deficits in sustained attention as assessed by undegraded and degraded continuous performance tests (CPTs). We also examined subgroups defined by deficits in categories achieved in the Wisconsin Card Sort Test (WCST). RESULTS Three of five candidate vulnerability genes (RASD2, APOL5, MYH9, EIF3S7, and CACNG2), which had marginally significant associations with schizophrenia, had significant associations with schizophrenic patients who did not have deficits in sustained attention on the undegraded CPT (RASD2 gene SNP rs736212; p = .0008 with single locus analysis) and the degraded CPT (MYH9 gene haplotype 1-1-1-1 of SNP rs3752463 - rs1557540 - rs713839 - rs739097; p = .0059 with haplotype analysis). We also found a significant association for patients who showed no deficits in executive function as measured by categories achieved in the WCST (CACNG2 gene haplotype 2-1-1-1 of SNP rs2267360 - rs140526 - rs1883987 - rs916269; p = .0163 with haplotype analysis). CONCLUSIONS The genes RASD2, MYH9, and CACNG2 might be vulnerability genes for neuropsychologically defined subgroups of schizophrenic patients.